Kim Suh Min, Min Seung-Kee, Park Daedo, Min Sang-Il, Jang Jin-Young, Kim Sun-Whe, Ha Jongwon, Kim Sang Joon
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
J Korean Surg Soc. 2013 Jun;84(6):346-52. doi: 10.4174/jkss.2013.84.6.346. Epub 2013 May 28.
Tumor invasion to the portal vein (PV) or superior mesenteric vein (SMV) can be encountered during the surgery for pancreatic cancer. Venous reconstruction is required, but the optimal surgical methods and conduits remain in controversies.
From January 2007 to July 2012, 16 venous reconstructions were performed during surgery for pancreatic cancer in 14 patients. We analyzed the methods, conduits, graft patency, and patient survival.
The involved veins were 14 SMVs and 2 PVs. The operative methods included resection and end-to-end anastomosis in 7 patients, wedge resection with venoplasty in 2 patients, bovine patch repair in 3 patients, and interposition graft with bovine patch in 1 patient. In one patient with a failed interposition graft with great saphenous vein (GSV), the SMV was reconstructed with a prosthetic interposition graft, which was revised with a spiral graft of GSV. Vascular morbidity occurred in 4 cases; occlusion of an interposition graft with GSV or polytetrafluoroethylene, segmental thrombosis and stenosis of the SMV after end-to-end anastomosis. Patency was maintained in patients with bovine patch angioplasty and spiral vein grafts. With mean follow-up of 9.8 months, the 6- and 12-month death-censored graft survival rates were both 81.3%.
Many of the involved vein segments were repaired primarily. When tension-free anastomosis is impossible, the spiral grafts with GSV or bovine patch grafts are good options to overcome the size mismatch between autologous vein graft and portomesenteric veins. Further follow-up of these patients is needed to demonstrate long-term patency.
胰腺癌手术过程中可能会遇到肿瘤侵犯门静脉(PV)或肠系膜上静脉(SMV)的情况。此时需要进行静脉重建,但最佳的手术方法和血管 conduit 仍存在争议。
2007年1月至2012年7月,14例胰腺癌患者在手术中进行了16次静脉重建。我们分析了手术方法、血管 conduit、移植血管通畅情况和患者生存率。
受累静脉为14条SMV和2条PV。手术方法包括7例切除并端端吻合、2例楔形切除并静脉成形术、3例牛心包补片修补术和1例带牛心包补片的间置移植术。1例大隐静脉(GSV)间置移植失败的患者,其SMV用人工血管间置移植重建,后用GSV螺旋移植进行了修正。4例发生血管并发症;GSV或聚四氟乙烯间置移植血管闭塞、端端吻合后SMV节段性血栓形成和狭窄。牛心包血管成形术和螺旋静脉移植患者的血管保持通畅。平均随访9.8个月,6个月和12个月的死亡校正移植血管生存率均为81.3%。
许多受累静脉段主要进行了修复。当无法进行无张力吻合时,GSV螺旋移植或牛心包补片移植是克服自体静脉移植与门静脉肠系膜静脉大小不匹配的良好选择。需要对这些患者进行进一步随访以证明长期通畅情况。